Mavpan-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30mg and Pantoprazole 40mg, designed to manage gastrointestinal disorders characterized by acid reflux, indigestion, and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of these two agents in Mavpan-DSR Capsule offers both symptomatic relief and promotes mucosal healing by reducing acid load and improving gastric motility. This combination is particularly beneficial in patients experiencing upper gastrointestinal motility disorders accompanied by acid hypersecretion. Mavpan-DSR should be used under medical supervision, with dosage adjusted according to clinical response and patient tolerance. Caution is advised in patients with known hypersensitivity to either component, and it is contraindicated in cases of gastrointestinal hemorrhage, obstruction, or perforation.